TAS1553;Benzamide, 5-chloro-2-[[[(1S,2R)-1-(4,5-dihydro-5-oxo-1,3,4-oxadiazol-2-yl)-2-(6-fluoro-2,3-dimethylphenyl)propyl]amino]sulfonyl]-;5-chloro-2-{[(1S,2R)-2-(6-fluoro-2,3-dimethylphenyl)-1-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)propyl]sulfamoyl}benzamide;TAS1553, 10 mM in DMSO
TAS1553 can be used in cancer research; it is a potent, orally active protein-protein interaction (PPI) inhibitor that induces apoptosis by inhibiting DNA replication and reducing intracellular dATP pools.